BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Science in Vancouver - ECPv6.15.18//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Science in Vancouver
X-ORIGINAL-URL:https://scienceinvancouver.com
X-WR-CALDESC:Events for Science in Vancouver
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/Vancouver
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20190310T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20191103T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20200308T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20201101T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20210314T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20211107T090000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20200420T090000
DTEND;TZID=America/Vancouver:20200420T100000
DTSTAMP:20260408T212148
CREATED:20200330T211501Z
LAST-MODIFIED:20200330T211501Z
UID:10894-1587373200-1587376800@scienceinvancouver.com
SUMMARY:Webinar: Hematopoietic Cell Therapy Products - Determining Potency and Stability
DESCRIPTION:There are unique challenges when it comes to cell therapy products\, including ensuring the reproducibility and consistency of product lots. These specific concerns arise from the inherent variability of the starting material\, which often comes from multiple patients or donors. Before using these cells as therapy\, the quality–including both purity and potency–of the final product must be established. This in turn requires reliable cell assays.\n\nThe best type of assay to measure the functionality of hematopoietic stem and progenitor cells (HSPCs) is an in vivo mouse model engraftment study; however\, these types of assays are time-consuming\, expensive\, and difficult to evaluate. Therefore\, the in vitro colony-forming unit (CFU) assay\, which has been shown to correlate well with in vivo engraftment models\, is recommended to evaluate the quality of HSPCs used in cell therapy. Several cord blood bank accrediting bodies (including AABB and FACT) now require pre-freeze CFU data from cord blood collection\, as evidence of sample stability and to ensure there is minimal loss of HSPCs during processing and cryopreservation.\n\nIn this webinar\, Dr. Jackie Damen of STEMCELL Technologies will explore the need for standardized potency assays for hematopoietic cell products and review recent publications that evaluate the effects of cryopreservation protocols on the potency of cell therapy products. Dr. Damen will define the CFU assay and explore its utility as part of the cell therapy workflow. She will also define simple steps that can help ensure standardization of the CFU assay\, including the use of automated imaging and analysis of cultures.\n\nLearning Objectives:\n\nDefine the CFU assay and its characteristics as a biological tool in identifying hematopoietic stem and progenitor cells\nIdentify publications using the CFU assay to verify the potency and stability of Hematopoietic Cellular Therapy Products\nUnderstand the utility of the CFU assay in the processing and manufacturing of Hematopoietic Cellular Therapy Products\n\n\n\nWebinars will be available for unlimited on-demand viewing after live event.\n\nLabRoots is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E. ® Program. By attending this webinar\, you can earn 1 Continuing Education credit once you have viewed the webinar in its entirety.
URL:https://scienceinvancouver.com/event/webinar-hematopoietic-cell-therapy-products-determining-potency-and-stability/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20200420T090000
DTEND;TZID=America/Vancouver:20200420T100000
DTSTAMP:20260408T212148
CREATED:20200330T211501Z
LAST-MODIFIED:20200330T211501Z
UID:26124-1587373200-1587376800@scienceinvancouver.com
SUMMARY:Webinar: Hematopoietic Cell Therapy Products - Determining Potency and Stability
DESCRIPTION:There are unique challenges when it comes to cell therapy products\, including ensuring the reproducibility and consistency of product lots. These specific concerns arise from the inherent variability of the starting material\, which often comes from multiple patients or donors. Before using these cells as therapy\, the quality–including both purity and potency–of the final product must be established. This in turn requires reliable cell assays.\n\nThe best type of assay to measure the functionality of hematopoietic stem and progenitor cells (HSPCs) is an in vivo mouse model engraftment study; however\, these types of assays are time-consuming\, expensive\, and difficult to evaluate. Therefore\, the in vitro colony-forming unit (CFU) assay\, which has been shown to correlate well with in vivo engraftment models\, is recommended to evaluate the quality of HSPCs used in cell therapy. Several cord blood bank accrediting bodies (including AABB and FACT) now require pre-freeze CFU data from cord blood collection\, as evidence of sample stability and to ensure there is minimal loss of HSPCs during processing and cryopreservation.\n\nIn this webinar\, Dr. Jackie Damen of STEMCELL Technologies will explore the need for standardized potency assays for hematopoietic cell products and review recent publications that evaluate the effects of cryopreservation protocols on the potency of cell therapy products. Dr. Damen will define the CFU assay and explore its utility as part of the cell therapy workflow. She will also define simple steps that can help ensure standardization of the CFU assay\, including the use of automated imaging and analysis of cultures.\n\nLearning Objectives:\n\nDefine the CFU assay and its characteristics as a biological tool in identifying hematopoietic stem and progenitor cells\nIdentify publications using the CFU assay to verify the potency and stability of Hematopoietic Cellular Therapy Products\nUnderstand the utility of the CFU assay in the processing and manufacturing of Hematopoietic Cellular Therapy Products\n\n\n\nWebinars will be available for unlimited on-demand viewing after live event.\n\nLabRoots is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E. ® Program. By attending this webinar\, you can earn 1 Continuing Education credit once you have viewed the webinar in its entirety.
URL:https://scienceinvancouver.com/event/webinar-hematopoietic-cell-therapy-products-determining-potency-and-stability-2/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20200420T090000
DTEND;TZID=America/Vancouver:20200420T100000
DTSTAMP:20260408T212148
CREATED:20200330T211501Z
LAST-MODIFIED:20200330T211501Z
UID:27739-1587373200-1587376800@scienceinvancouver.com
SUMMARY:Webinar: Hematopoietic Cell Therapy Products - Determining Potency and Stability
DESCRIPTION:There are unique challenges when it comes to cell therapy products\, including ensuring the reproducibility and consistency of product lots. These specific concerns arise from the inherent variability of the starting material\, which often comes from multiple patients or donors. Before using these cells as therapy\, the quality–including both purity and potency–of the final product must be established. This in turn requires reliable cell assays.\n\nThe best type of assay to measure the functionality of hematopoietic stem and progenitor cells (HSPCs) is an in vivo mouse model engraftment study; however\, these types of assays are time-consuming\, expensive\, and difficult to evaluate. Therefore\, the in vitro colony-forming unit (CFU) assay\, which has been shown to correlate well with in vivo engraftment models\, is recommended to evaluate the quality of HSPCs used in cell therapy. Several cord blood bank accrediting bodies (including AABB and FACT) now require pre-freeze CFU data from cord blood collection\, as evidence of sample stability and to ensure there is minimal loss of HSPCs during processing and cryopreservation.\n\nIn this webinar\, Dr. Jackie Damen of STEMCELL Technologies will explore the need for standardized potency assays for hematopoietic cell products and review recent publications that evaluate the effects of cryopreservation protocols on the potency of cell therapy products. Dr. Damen will define the CFU assay and explore its utility as part of the cell therapy workflow. She will also define simple steps that can help ensure standardization of the CFU assay\, including the use of automated imaging and analysis of cultures.\n\nLearning Objectives:\n\nDefine the CFU assay and its characteristics as a biological tool in identifying hematopoietic stem and progenitor cells\nIdentify publications using the CFU assay to verify the potency and stability of Hematopoietic Cellular Therapy Products\nUnderstand the utility of the CFU assay in the processing and manufacturing of Hematopoietic Cellular Therapy Products\n\n\n\nWebinars will be available for unlimited on-demand viewing after live event.\n\nLabRoots is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E. ® Program. By attending this webinar\, you can earn 1 Continuing Education credit once you have viewed the webinar in its entirety.
URL:https://scienceinvancouver.com/event/webinar-hematopoietic-cell-therapy-products-determining-potency-and-stability-3/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20200420T090000
DTEND;TZID=America/Vancouver:20200420T100000
DTSTAMP:20260408T212148
CREATED:20200330T211501Z
LAST-MODIFIED:20200330T211501Z
UID:30822-1587373200-1587376800@scienceinvancouver.com
SUMMARY:Webinar: Hematopoietic Cell Therapy Products - Determining Potency and Stability
DESCRIPTION:There are unique challenges when it comes to cell therapy products\, including ensuring the reproducibility and consistency of product lots. These specific concerns arise from the inherent variability of the starting material\, which often comes from multiple patients or donors. Before using these cells as therapy\, the quality–including both purity and potency–of the final product must be established. This in turn requires reliable cell assays.\n\nThe best type of assay to measure the functionality of hematopoietic stem and progenitor cells (HSPCs) is an in vivo mouse model engraftment study; however\, these types of assays are time-consuming\, expensive\, and difficult to evaluate. Therefore\, the in vitro colony-forming unit (CFU) assay\, which has been shown to correlate well with in vivo engraftment models\, is recommended to evaluate the quality of HSPCs used in cell therapy. Several cord blood bank accrediting bodies (including AABB and FACT) now require pre-freeze CFU data from cord blood collection\, as evidence of sample stability and to ensure there is minimal loss of HSPCs during processing and cryopreservation.\n\nIn this webinar\, Dr. Jackie Damen of STEMCELL Technologies will explore the need for standardized potency assays for hematopoietic cell products and review recent publications that evaluate the effects of cryopreservation protocols on the potency of cell therapy products. Dr. Damen will define the CFU assay and explore its utility as part of the cell therapy workflow. She will also define simple steps that can help ensure standardization of the CFU assay\, including the use of automated imaging and analysis of cultures.\n\nLearning Objectives:\n\nDefine the CFU assay and its characteristics as a biological tool in identifying hematopoietic stem and progenitor cells\nIdentify publications using the CFU assay to verify the potency and stability of Hematopoietic Cellular Therapy Products\nUnderstand the utility of the CFU assay in the processing and manufacturing of Hematopoietic Cellular Therapy Products\n\n\n\nWebinars will be available for unlimited on-demand viewing after live event.\n\nLabRoots is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E. ® Program. By attending this webinar\, you can earn 1 Continuing Education credit once you have viewed the webinar in its entirety.
URL:https://scienceinvancouver.com/event/webinar-hematopoietic-cell-therapy-products-determining-potency-and-stability-4/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20200420T090000
DTEND;TZID=America/Vancouver:20200420T100000
DTSTAMP:20260408T212148
CREATED:20200330T211501Z
LAST-MODIFIED:20200330T211501Z
UID:32282-1587373200-1587376800@scienceinvancouver.com
SUMMARY:Webinar: Hematopoietic Cell Therapy Products - Determining Potency and Stability
DESCRIPTION:There are unique challenges when it comes to cell therapy products\, including ensuring the reproducibility and consistency of product lots. These specific concerns arise from the inherent variability of the starting material\, which often comes from multiple patients or donors. Before using these cells as therapy\, the quality–including both purity and potency–of the final product must be established. This in turn requires reliable cell assays.\n\nThe best type of assay to measure the functionality of hematopoietic stem and progenitor cells (HSPCs) is an in vivo mouse model engraftment study; however\, these types of assays are time-consuming\, expensive\, and difficult to evaluate. Therefore\, the in vitro colony-forming unit (CFU) assay\, which has been shown to correlate well with in vivo engraftment models\, is recommended to evaluate the quality of HSPCs used in cell therapy. Several cord blood bank accrediting bodies (including AABB and FACT) now require pre-freeze CFU data from cord blood collection\, as evidence of sample stability and to ensure there is minimal loss of HSPCs during processing and cryopreservation.\n\nIn this webinar\, Dr. Jackie Damen of STEMCELL Technologies will explore the need for standardized potency assays for hematopoietic cell products and review recent publications that evaluate the effects of cryopreservation protocols on the potency of cell therapy products. Dr. Damen will define the CFU assay and explore its utility as part of the cell therapy workflow. She will also define simple steps that can help ensure standardization of the CFU assay\, including the use of automated imaging and analysis of cultures.\n\nLearning Objectives:\n\nDefine the CFU assay and its characteristics as a biological tool in identifying hematopoietic stem and progenitor cells\nIdentify publications using the CFU assay to verify the potency and stability of Hematopoietic Cellular Therapy Products\nUnderstand the utility of the CFU assay in the processing and manufacturing of Hematopoietic Cellular Therapy Products\n\n\n\nWebinars will be available for unlimited on-demand viewing after live event.\n\nLabRoots is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E. ® Program. By attending this webinar\, you can earn 1 Continuing Education credit once you have viewed the webinar in its entirety.
URL:https://scienceinvancouver.com/event/webinar-hematopoietic-cell-therapy-products-determining-potency-and-stability-5/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20200420T120000
DTEND;TZID=America/Vancouver:20200420T130000
DTSTAMP:20260408T212148
CREATED:20200417T210158Z
LAST-MODIFIED:20200417T210158Z
UID:11123-1587384000-1587387600@scienceinvancouver.com
SUMMARY:Responding to COVID-19: Opportunities for All Researchers to Engage
DESCRIPTION:Right now\, all eyes are on an urgent science issue and its effects on our society. While everyone has a role to play in reducing the spread of the virus\, scientists have unique opportunities to respond to the crisis in impactful ways. For example\, some scientists might volunteer their lab or data analysis skills. Regardless of discipline\, researchers may find opportunities to pivot their research agenda to address timely and relevant questions. And others might serve as voices for science to amplify evidence\, reduce the spread of misinformation\, and advocate for science-informed approaches to managing the pandemic. This online panel discussion will include researchers from different disciplines who will share ideas for scientists looking to respond in the current moment.
URL:https://scienceinvancouver.com/event/responding-to-covid-19-opportunities-for-all-researchers-to-engage/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20200420T120000
DTEND;TZID=America/Vancouver:20200420T130000
DTSTAMP:20260408T212148
CREATED:20200417T210158Z
LAST-MODIFIED:20200417T210158Z
UID:26143-1587384000-1587387600@scienceinvancouver.com
SUMMARY:Responding to COVID-19: Opportunities for All Researchers to Engage
DESCRIPTION:Right now\, all eyes are on an urgent science issue and its effects on our society. While everyone has a role to play in reducing the spread of the virus\, scientists have unique opportunities to respond to the crisis in impactful ways. For example\, some scientists might volunteer their lab or data analysis skills. Regardless of discipline\, researchers may find opportunities to pivot their research agenda to address timely and relevant questions. And others might serve as voices for science to amplify evidence\, reduce the spread of misinformation\, and advocate for science-informed approaches to managing the pandemic. This online panel discussion will include researchers from different disciplines who will share ideas for scientists looking to respond in the current moment.
URL:https://scienceinvancouver.com/event/responding-to-covid-19-opportunities-for-all-researchers-to-engage-2/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20200420T120000
DTEND;TZID=America/Vancouver:20200420T130000
DTSTAMP:20260408T212148
CREATED:20200417T210158Z
LAST-MODIFIED:20200417T210158Z
UID:27758-1587384000-1587387600@scienceinvancouver.com
SUMMARY:Responding to COVID-19: Opportunities for All Researchers to Engage
DESCRIPTION:Right now\, all eyes are on an urgent science issue and its effects on our society. While everyone has a role to play in reducing the spread of the virus\, scientists have unique opportunities to respond to the crisis in impactful ways. For example\, some scientists might volunteer their lab or data analysis skills. Regardless of discipline\, researchers may find opportunities to pivot their research agenda to address timely and relevant questions. And others might serve as voices for science to amplify evidence\, reduce the spread of misinformation\, and advocate for science-informed approaches to managing the pandemic. This online panel discussion will include researchers from different disciplines who will share ideas for scientists looking to respond in the current moment.
URL:https://scienceinvancouver.com/event/responding-to-covid-19-opportunities-for-all-researchers-to-engage-3/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20200420T120000
DTEND;TZID=America/Vancouver:20200420T130000
DTSTAMP:20260408T212148
CREATED:20200417T210158Z
LAST-MODIFIED:20200417T210158Z
UID:30841-1587384000-1587387600@scienceinvancouver.com
SUMMARY:Responding to COVID-19: Opportunities for All Researchers to Engage
DESCRIPTION:Right now\, all eyes are on an urgent science issue and its effects on our society. While everyone has a role to play in reducing the spread of the virus\, scientists have unique opportunities to respond to the crisis in impactful ways. For example\, some scientists might volunteer their lab or data analysis skills. Regardless of discipline\, researchers may find opportunities to pivot their research agenda to address timely and relevant questions. And others might serve as voices for science to amplify evidence\, reduce the spread of misinformation\, and advocate for science-informed approaches to managing the pandemic. This online panel discussion will include researchers from different disciplines who will share ideas for scientists looking to respond in the current moment.
URL:https://scienceinvancouver.com/event/responding-to-covid-19-opportunities-for-all-researchers-to-engage-4/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20200420T120000
DTEND;TZID=America/Vancouver:20200420T130000
DTSTAMP:20260408T212148
CREATED:20200417T210158Z
LAST-MODIFIED:20200417T210158Z
UID:32301-1587384000-1587387600@scienceinvancouver.com
SUMMARY:Responding to COVID-19: Opportunities for All Researchers to Engage
DESCRIPTION:Right now\, all eyes are on an urgent science issue and its effects on our society. While everyone has a role to play in reducing the spread of the virus\, scientists have unique opportunities to respond to the crisis in impactful ways. For example\, some scientists might volunteer their lab or data analysis skills. Regardless of discipline\, researchers may find opportunities to pivot their research agenda to address timely and relevant questions. And others might serve as voices for science to amplify evidence\, reduce the spread of misinformation\, and advocate for science-informed approaches to managing the pandemic. This online panel discussion will include researchers from different disciplines who will share ideas for scientists looking to respond in the current moment.
URL:https://scienceinvancouver.com/event/responding-to-covid-19-opportunities-for-all-researchers-to-engage-5/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20200421T100000
DTEND;TZID=America/Vancouver:20200421T110000
DTSTAMP:20260408T212148
CREATED:20200326T172703Z
LAST-MODIFIED:20200326T172703Z
UID:10834-1587463200-1587466800@scienceinvancouver.com
SUMMARY:North American Vascular Biology Organization (NAVBO) Online Mini-Symposia
DESCRIPTION:An online mini-symposium featuring four presentations:\n\nRenal stromal netrin-1 signaling drives kidney arterial development (Xiaowu Gu\, UT Southwestern)\nInhibition of Notch signaling in pericytes leads to AVM-like lesions (Taliha Nadeem\, University of Illinois\, Chicago)\nDach1 Promotes Coronary Artery Endothelial Cell Specification (Brian Raftrey\, Stanford University)\nPro-angiogenic properties of Purified Exosome Product (PEP) (Ao Shi\, Mayo Clinic) The session will be moderated by Kayla Bayless\, Texas A&M University
URL:https://scienceinvancouver.com/event/north-american-vascular-biology-organization-navbo-online-mini-symposia/
LOCATION:Online
ATTACH;FMTTYPE=image/jpeg:https://scienceinvancouver.com/wp-content/uploads/sites/1/2020/03/NAVBO.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20200421T100000
DTEND;TZID=America/Vancouver:20200421T110000
DTSTAMP:20260408T212148
CREATED:20200326T172703Z
LAST-MODIFIED:20200326T172703Z
UID:26117-1587463200-1587466800@scienceinvancouver.com
SUMMARY:North American Vascular Biology Organization (NAVBO) Online Mini-Symposia
DESCRIPTION:An online mini-symposium featuring four presentations:\n\nRenal stromal netrin-1 signaling drives kidney arterial development (Xiaowu Gu\, UT Southwestern)\nInhibition of Notch signaling in pericytes leads to AVM-like lesions (Taliha Nadeem\, University of Illinois\, Chicago)\nDach1 Promotes Coronary Artery Endothelial Cell Specification (Brian Raftrey\, Stanford University)\nPro-angiogenic properties of Purified Exosome Product (PEP) (Ao Shi\, Mayo Clinic) The session will be moderated by Kayla Bayless\, Texas A&M University
URL:https://scienceinvancouver.com/event/north-american-vascular-biology-organization-navbo-online-mini-symposia-2/
LOCATION:Online
ATTACH;FMTTYPE=image/jpeg:https://scienceinvancouver.com/wp-content/uploads/sites/1/2020/03/NAVBO.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20200421T100000
DTEND;TZID=America/Vancouver:20200421T110000
DTSTAMP:20260408T212148
CREATED:20200326T172703Z
LAST-MODIFIED:20200326T172703Z
UID:27735-1587463200-1587466800@scienceinvancouver.com
SUMMARY:North American Vascular Biology Organization (NAVBO) Online Mini-Symposia
DESCRIPTION:An online mini-symposium featuring four presentations:\n\nRenal stromal netrin-1 signaling drives kidney arterial development (Xiaowu Gu\, UT Southwestern)\nInhibition of Notch signaling in pericytes leads to AVM-like lesions (Taliha Nadeem\, University of Illinois\, Chicago)\nDach1 Promotes Coronary Artery Endothelial Cell Specification (Brian Raftrey\, Stanford University)\nPro-angiogenic properties of Purified Exosome Product (PEP) (Ao Shi\, Mayo Clinic) The session will be moderated by Kayla Bayless\, Texas A&M University
URL:https://scienceinvancouver.com/event/north-american-vascular-biology-organization-navbo-online-mini-symposia-3/
LOCATION:Online
ATTACH;FMTTYPE=image/jpeg:https://scienceinvancouver.com/wp-content/uploads/sites/1/2020/03/NAVBO.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20200421T100000
DTEND;TZID=America/Vancouver:20200421T110000
DTSTAMP:20260408T212148
CREATED:20200326T172703Z
LAST-MODIFIED:20200326T172703Z
UID:30818-1587463200-1587466800@scienceinvancouver.com
SUMMARY:North American Vascular Biology Organization (NAVBO) Online Mini-Symposia
DESCRIPTION:An online mini-symposium featuring four presentations:\n\nRenal stromal netrin-1 signaling drives kidney arterial development (Xiaowu Gu\, UT Southwestern)\nInhibition of Notch signaling in pericytes leads to AVM-like lesions (Taliha Nadeem\, University of Illinois\, Chicago)\nDach1 Promotes Coronary Artery Endothelial Cell Specification (Brian Raftrey\, Stanford University)\nPro-angiogenic properties of Purified Exosome Product (PEP) (Ao Shi\, Mayo Clinic) The session will be moderated by Kayla Bayless\, Texas A&M University
URL:https://scienceinvancouver.com/event/north-american-vascular-biology-organization-navbo-online-mini-symposia-4/
LOCATION:Online
ATTACH;FMTTYPE=image/jpeg:https://scienceinvancouver.com/wp-content/uploads/sites/1/2020/03/NAVBO.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20200421T100000
DTEND;TZID=America/Vancouver:20200421T110000
DTSTAMP:20260408T212148
CREATED:20200326T172703Z
LAST-MODIFIED:20200326T172703Z
UID:32278-1587463200-1587466800@scienceinvancouver.com
SUMMARY:North American Vascular Biology Organization (NAVBO) Online Mini-Symposia
DESCRIPTION:An online mini-symposium featuring four presentations:\n\nRenal stromal netrin-1 signaling drives kidney arterial development (Xiaowu Gu\, UT Southwestern)\nInhibition of Notch signaling in pericytes leads to AVM-like lesions (Taliha Nadeem\, University of Illinois\, Chicago)\nDach1 Promotes Coronary Artery Endothelial Cell Specification (Brian Raftrey\, Stanford University)\nPro-angiogenic properties of Purified Exosome Product (PEP) (Ao Shi\, Mayo Clinic) The session will be moderated by Kayla Bayless\, Texas A&M University
URL:https://scienceinvancouver.com/event/north-american-vascular-biology-organization-navbo-online-mini-symposia-5/
LOCATION:Online
ATTACH;FMTTYPE=image/jpeg:https://scienceinvancouver.com/wp-content/uploads/sites/1/2020/03/NAVBO.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20200421T120000
DTEND;TZID=America/Vancouver:20200421T130000
DTSTAMP:20260408T212148
CREATED:20200415T182606Z
LAST-MODIFIED:20200415T182606Z
UID:11094-1587470400-1587474000@scienceinvancouver.com
SUMMARY:Special LINUS Report: Major Updates on Scientific Progress Amidst a Global Pandemic
DESCRIPTION:Having embarked on a longitudinal study to understand the impact of Coronavirus across life sciences\, we have identified four phases for how the pandemic will cause disruptions to the industry. Now\, with a second major data-collection time point\, and over 2\,000 respondents\, we have found major updates on what the life science community is thinking\, feeling and doing as coronavirus continues to affect our realities and shapes productivity. In this next wave of our research\, we will reveal the magnitude of the disruption to productivity\, the progress of workplace transitions\, and the developing sentiment felt across the industry.
URL:https://scienceinvancouver.com/event/special-linus-report-major-updates-on-scientific-progress-amidst-a-global-pandemic/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20200421T120000
DTEND;TZID=America/Vancouver:20200421T130000
DTSTAMP:20260408T212148
CREATED:20200415T182606Z
LAST-MODIFIED:20200415T182606Z
UID:26139-1587470400-1587474000@scienceinvancouver.com
SUMMARY:Special LINUS Report: Major Updates on Scientific Progress Amidst a Global Pandemic
DESCRIPTION:Having embarked on a longitudinal study to understand the impact of Coronavirus across life sciences\, we have identified four phases for how the pandemic will cause disruptions to the industry. Now\, with a second major data-collection time point\, and over 2\,000 respondents\, we have found major updates on what the life science community is thinking\, feeling and doing as coronavirus continues to affect our realities and shapes productivity. In this next wave of our research\, we will reveal the magnitude of the disruption to productivity\, the progress of workplace transitions\, and the developing sentiment felt across the industry.
URL:https://scienceinvancouver.com/event/special-linus-report-major-updates-on-scientific-progress-amidst-a-global-pandemic-2/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20200421T120000
DTEND;TZID=America/Vancouver:20200421T130000
DTSTAMP:20260408T212148
CREATED:20200415T182606Z
LAST-MODIFIED:20200415T182606Z
UID:27754-1587470400-1587474000@scienceinvancouver.com
SUMMARY:Special LINUS Report: Major Updates on Scientific Progress Amidst a Global Pandemic
DESCRIPTION:Having embarked on a longitudinal study to understand the impact of Coronavirus across life sciences\, we have identified four phases for how the pandemic will cause disruptions to the industry. Now\, with a second major data-collection time point\, and over 2\,000 respondents\, we have found major updates on what the life science community is thinking\, feeling and doing as coronavirus continues to affect our realities and shapes productivity. In this next wave of our research\, we will reveal the magnitude of the disruption to productivity\, the progress of workplace transitions\, and the developing sentiment felt across the industry.
URL:https://scienceinvancouver.com/event/special-linus-report-major-updates-on-scientific-progress-amidst-a-global-pandemic-3/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20200421T120000
DTEND;TZID=America/Vancouver:20200421T130000
DTSTAMP:20260408T212148
CREATED:20200415T182606Z
LAST-MODIFIED:20200415T182606Z
UID:30837-1587470400-1587474000@scienceinvancouver.com
SUMMARY:Special LINUS Report: Major Updates on Scientific Progress Amidst a Global Pandemic
DESCRIPTION:Having embarked on a longitudinal study to understand the impact of Coronavirus across life sciences\, we have identified four phases for how the pandemic will cause disruptions to the industry. Now\, with a second major data-collection time point\, and over 2\,000 respondents\, we have found major updates on what the life science community is thinking\, feeling and doing as coronavirus continues to affect our realities and shapes productivity. In this next wave of our research\, we will reveal the magnitude of the disruption to productivity\, the progress of workplace transitions\, and the developing sentiment felt across the industry.
URL:https://scienceinvancouver.com/event/special-linus-report-major-updates-on-scientific-progress-amidst-a-global-pandemic-4/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20200421T120000
DTEND;TZID=America/Vancouver:20200421T130000
DTSTAMP:20260408T212148
CREATED:20200415T182606Z
LAST-MODIFIED:20200415T182606Z
UID:32297-1587470400-1587474000@scienceinvancouver.com
SUMMARY:Special LINUS Report: Major Updates on Scientific Progress Amidst a Global Pandemic
DESCRIPTION:Having embarked on a longitudinal study to understand the impact of Coronavirus across life sciences\, we have identified four phases for how the pandemic will cause disruptions to the industry. Now\, with a second major data-collection time point\, and over 2\,000 respondents\, we have found major updates on what the life science community is thinking\, feeling and doing as coronavirus continues to affect our realities and shapes productivity. In this next wave of our research\, we will reveal the magnitude of the disruption to productivity\, the progress of workplace transitions\, and the developing sentiment felt across the industry.
URL:https://scienceinvancouver.com/event/special-linus-report-major-updates-on-scientific-progress-amidst-a-global-pandemic-5/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20200421T130000
DTEND;TZID=America/Vancouver:20200421T140000
DTSTAMP:20260408T212148
CREATED:20200415T154430Z
LAST-MODIFIED:20200415T154430Z
UID:11080-1587474000-1587477600@scienceinvancouver.com
SUMMARY:How to Navigate Fast Track Approval during COVID-19
DESCRIPTION:During these times of uncertainty\, LifeSciences BC hopes to offer support in any way it can. This webinar is free for everyone.\n\n\n\n\n\n\nAbout this Event\n\n\nDuring these times of uncertainty\, LifeSciences BC hopes to offer support in any way it can. As we are all practicing social distancing in an effort to flatten the curve\, we are offering this free webinar\, sponsored by Novateur Ventures for companies who are looking for a way to fast-track the approval process for their products. \nConfirmed Speakers: \n\nThomas Digby – Global IP Lead – Novateur Ventures\nIan McGill – Lead US Diagnostics Regulatory Affairs – Novateur Ventures\n\n\n\nFor more information\, please contact: \nRyan Butt \nSenior Manager\, Events & Outreach \nPhone: (604) 669-9909 ext. 104 \nEmail: rbutt@lifesciencesbc.ca
URL:https://scienceinvancouver.com/event/how-to-navigate-fast-track-approval-during-covid-19/
LOCATION:Online
ATTACH;FMTTYPE=image/jpeg:https://scienceinvancouver.com/wp-content/uploads/sites/1/2020/04/How-to-Navigate-Fast-Track-Approval-during-COVID-19.jpeg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20200421T130000
DTEND;TZID=America/Vancouver:20200421T140000
DTSTAMP:20260408T212148
CREATED:20200415T154430Z
LAST-MODIFIED:20200415T154430Z
UID:26135-1587474000-1587477600@scienceinvancouver.com
SUMMARY:How to Navigate Fast Track Approval during COVID-19
DESCRIPTION:During these times of uncertainty\, LifeSciences BC hopes to offer support in any way it can. This webinar is free for everyone.\n\n\n\n\n\n\nAbout this Event\n\n\nDuring these times of uncertainty\, LifeSciences BC hopes to offer support in any way it can. As we are all practicing social distancing in an effort to flatten the curve\, we are offering this free webinar\, sponsored by Novateur Ventures for companies who are looking for a way to fast-track the approval process for their products. \nConfirmed Speakers: \n\nThomas Digby – Global IP Lead – Novateur Ventures\nIan McGill – Lead US Diagnostics Regulatory Affairs – Novateur Ventures\n\n\n\nFor more information\, please contact: \nRyan Butt \nSenior Manager\, Events & Outreach \nPhone: (604) 669-9909 ext. 104 \nEmail: rbutt@lifesciencesbc.ca
URL:https://scienceinvancouver.com/event/how-to-navigate-fast-track-approval-during-covid-19-2/
LOCATION:Online
ATTACH;FMTTYPE=image/jpeg:https://scienceinvancouver.com/wp-content/uploads/sites/1/2020/04/How-to-Navigate-Fast-Track-Approval-during-COVID-19.jpeg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20200421T130000
DTEND;TZID=America/Vancouver:20200421T140000
DTSTAMP:20260408T212148
CREATED:20200415T154430Z
LAST-MODIFIED:20200415T154430Z
UID:27750-1587474000-1587477600@scienceinvancouver.com
SUMMARY:How to Navigate Fast Track Approval during COVID-19
DESCRIPTION:During these times of uncertainty\, LifeSciences BC hopes to offer support in any way it can. This webinar is free for everyone.\n\n\n\n\n\n\nAbout this Event\n\n\nDuring these times of uncertainty\, LifeSciences BC hopes to offer support in any way it can. As we are all practicing social distancing in an effort to flatten the curve\, we are offering this free webinar\, sponsored by Novateur Ventures for companies who are looking for a way to fast-track the approval process for their products. \nConfirmed Speakers: \n\nThomas Digby – Global IP Lead – Novateur Ventures\nIan McGill – Lead US Diagnostics Regulatory Affairs – Novateur Ventures\n\n\n\nFor more information\, please contact: \nRyan Butt \nSenior Manager\, Events & Outreach \nPhone: (604) 669-9909 ext. 104 \nEmail: rbutt@lifesciencesbc.ca
URL:https://scienceinvancouver.com/event/how-to-navigate-fast-track-approval-during-covid-19-3/
LOCATION:Online
ATTACH;FMTTYPE=image/jpeg:https://scienceinvancouver.com/wp-content/uploads/sites/1/2020/04/How-to-Navigate-Fast-Track-Approval-during-COVID-19.jpeg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20200421T130000
DTEND;TZID=America/Vancouver:20200421T140000
DTSTAMP:20260408T212148
CREATED:20200415T154430Z
LAST-MODIFIED:20200415T154430Z
UID:30833-1587474000-1587477600@scienceinvancouver.com
SUMMARY:How to Navigate Fast Track Approval during COVID-19
DESCRIPTION:During these times of uncertainty\, LifeSciences BC hopes to offer support in any way it can. This webinar is free for everyone.\n\n\n\n\n\n\nAbout this Event\n\n\nDuring these times of uncertainty\, LifeSciences BC hopes to offer support in any way it can. As we are all practicing social distancing in an effort to flatten the curve\, we are offering this free webinar\, sponsored by Novateur Ventures for companies who are looking for a way to fast-track the approval process for their products. \nConfirmed Speakers: \n\nThomas Digby – Global IP Lead – Novateur Ventures\nIan McGill – Lead US Diagnostics Regulatory Affairs – Novateur Ventures\n\n\n\nFor more information\, please contact: \nRyan Butt \nSenior Manager\, Events & Outreach \nPhone: (604) 669-9909 ext. 104 \nEmail: rbutt@lifesciencesbc.ca
URL:https://scienceinvancouver.com/event/how-to-navigate-fast-track-approval-during-covid-19-4/
LOCATION:Online
ATTACH;FMTTYPE=image/jpeg:https://scienceinvancouver.com/wp-content/uploads/sites/1/2020/04/How-to-Navigate-Fast-Track-Approval-during-COVID-19.jpeg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20200421T130000
DTEND;TZID=America/Vancouver:20200421T140000
DTSTAMP:20260408T212148
CREATED:20200415T154430Z
LAST-MODIFIED:20200415T154430Z
UID:32293-1587474000-1587477600@scienceinvancouver.com
SUMMARY:How to Navigate Fast Track Approval during COVID-19
DESCRIPTION:During these times of uncertainty\, LifeSciences BC hopes to offer support in any way it can. This webinar is free for everyone.\n\n\n\n\n\n\nAbout this Event\n\n\nDuring these times of uncertainty\, LifeSciences BC hopes to offer support in any way it can. As we are all practicing social distancing in an effort to flatten the curve\, we are offering this free webinar\, sponsored by Novateur Ventures for companies who are looking for a way to fast-track the approval process for their products. \nConfirmed Speakers: \n\nThomas Digby – Global IP Lead – Novateur Ventures\nIan McGill – Lead US Diagnostics Regulatory Affairs – Novateur Ventures\n\n\n\nFor more information\, please contact: \nRyan Butt \nSenior Manager\, Events & Outreach \nPhone: (604) 669-9909 ext. 104 \nEmail: rbutt@lifesciencesbc.ca
URL:https://scienceinvancouver.com/event/how-to-navigate-fast-track-approval-during-covid-19-5/
LOCATION:Online
ATTACH;FMTTYPE=image/jpeg:https://scienceinvancouver.com/wp-content/uploads/sites/1/2020/04/How-to-Navigate-Fast-Track-Approval-during-COVID-19.jpeg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20200422T080000
DTEND;TZID=America/Vancouver:20200425T170000
DTSTAMP:20260408T212148
CREATED:20200413T220525Z
LAST-MODIFIED:20200413T220525Z
UID:11070-1587542400-1587834000@scienceinvancouver.com
SUMMARY:The Allied Genetics Conference (TAGC) Online
DESCRIPTION:TAGC is a unique conference organized by the Genetics Society of America that fosters collaboration by alternating community-specific sessions with cross-community thematic sessions. After the in-person version of the meeting was canceled\, we recreated TAGC Online as a virtual meeting that allows you to share your research and stay connected without leaving your home. \nJoin us online April 22–25\, 2020. There is no cost to attend\, but you must register in advance! \nAt TAGC Online you can join colleagues from the C. elegans\,  Drosophila\, mammalian\, Xenopus\, yeast\, zebrafish\, and population\, evolutionary\, and quantitative genetics (PEQG) research communities—along with other researchers studying humans\, plants\, and agricultural species. In addition to the Community Sessions\, Thematic Sessions bring the communities together around unifying themes. \nOn April 22–25\, both Community and Thematic Sessions will be presented live online. TAGC 2020 Online will also include posters and inspiring Keynote Speakers\, followed by a program of poster discussion sessions and two-hour workshops in the weeks after the main event. TAGC 2020 is organized by dedicated members of the GSA community. We hope you’ll join us for this exciting experiment!
URL:https://scienceinvancouver.com/event/the-allied-genetics-conference-tagc-online/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20200422T080000
DTEND;TZID=America/Vancouver:20200425T170000
DTSTAMP:20260408T212148
CREATED:20200413T220525Z
LAST-MODIFIED:20200413T220525Z
UID:26133-1587542400-1587834000@scienceinvancouver.com
SUMMARY:The Allied Genetics Conference (TAGC) Online
DESCRIPTION:TAGC is a unique conference organized by the Genetics Society of America that fosters collaboration by alternating community-specific sessions with cross-community thematic sessions. After the in-person version of the meeting was canceled\, we recreated TAGC Online as a virtual meeting that allows you to share your research and stay connected without leaving your home. \nJoin us online April 22–25\, 2020. There is no cost to attend\, but you must register in advance! \nAt TAGC Online you can join colleagues from the C. elegans\,  Drosophila\, mammalian\, Xenopus\, yeast\, zebrafish\, and population\, evolutionary\, and quantitative genetics (PEQG) research communities—along with other researchers studying humans\, plants\, and agricultural species. In addition to the Community Sessions\, Thematic Sessions bring the communities together around unifying themes. \nOn April 22–25\, both Community and Thematic Sessions will be presented live online. TAGC 2020 Online will also include posters and inspiring Keynote Speakers\, followed by a program of poster discussion sessions and two-hour workshops in the weeks after the main event. TAGC 2020 is organized by dedicated members of the GSA community. We hope you’ll join us for this exciting experiment!
URL:https://scienceinvancouver.com/event/the-allied-genetics-conference-tagc-online-2/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20200422T080000
DTEND;TZID=America/Vancouver:20200425T170000
DTSTAMP:20260408T212148
CREATED:20200413T220525Z
LAST-MODIFIED:20200413T220525Z
UID:27748-1587542400-1587834000@scienceinvancouver.com
SUMMARY:The Allied Genetics Conference (TAGC) Online
DESCRIPTION:TAGC is a unique conference organized by the Genetics Society of America that fosters collaboration by alternating community-specific sessions with cross-community thematic sessions. After the in-person version of the meeting was canceled\, we recreated TAGC Online as a virtual meeting that allows you to share your research and stay connected without leaving your home. \nJoin us online April 22–25\, 2020. There is no cost to attend\, but you must register in advance! \nAt TAGC Online you can join colleagues from the C. elegans\,  Drosophila\, mammalian\, Xenopus\, yeast\, zebrafish\, and population\, evolutionary\, and quantitative genetics (PEQG) research communities—along with other researchers studying humans\, plants\, and agricultural species. In addition to the Community Sessions\, Thematic Sessions bring the communities together around unifying themes. \nOn April 22–25\, both Community and Thematic Sessions will be presented live online. TAGC 2020 Online will also include posters and inspiring Keynote Speakers\, followed by a program of poster discussion sessions and two-hour workshops in the weeks after the main event. TAGC 2020 is organized by dedicated members of the GSA community. We hope you’ll join us for this exciting experiment!
URL:https://scienceinvancouver.com/event/the-allied-genetics-conference-tagc-online-3/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20200422T080000
DTEND;TZID=America/Vancouver:20200425T170000
DTSTAMP:20260408T212148
CREATED:20200413T220525Z
LAST-MODIFIED:20200413T220525Z
UID:30831-1587542400-1587834000@scienceinvancouver.com
SUMMARY:The Allied Genetics Conference (TAGC) Online
DESCRIPTION:TAGC is a unique conference organized by the Genetics Society of America that fosters collaboration by alternating community-specific sessions with cross-community thematic sessions. After the in-person version of the meeting was canceled\, we recreated TAGC Online as a virtual meeting that allows you to share your research and stay connected without leaving your home. \nJoin us online April 22–25\, 2020. There is no cost to attend\, but you must register in advance! \nAt TAGC Online you can join colleagues from the C. elegans\,  Drosophila\, mammalian\, Xenopus\, yeast\, zebrafish\, and population\, evolutionary\, and quantitative genetics (PEQG) research communities—along with other researchers studying humans\, plants\, and agricultural species. In addition to the Community Sessions\, Thematic Sessions bring the communities together around unifying themes. \nOn April 22–25\, both Community and Thematic Sessions will be presented live online. TAGC 2020 Online will also include posters and inspiring Keynote Speakers\, followed by a program of poster discussion sessions and two-hour workshops in the weeks after the main event. TAGC 2020 is organized by dedicated members of the GSA community. We hope you’ll join us for this exciting experiment!
URL:https://scienceinvancouver.com/event/the-allied-genetics-conference-tagc-online-4/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20200422T080000
DTEND;TZID=America/Vancouver:20200425T170000
DTSTAMP:20260408T212148
CREATED:20200413T220525Z
LAST-MODIFIED:20200413T220525Z
UID:32291-1587542400-1587834000@scienceinvancouver.com
SUMMARY:The Allied Genetics Conference (TAGC) Online
DESCRIPTION:TAGC is a unique conference organized by the Genetics Society of America that fosters collaboration by alternating community-specific sessions with cross-community thematic sessions. After the in-person version of the meeting was canceled\, we recreated TAGC Online as a virtual meeting that allows you to share your research and stay connected without leaving your home. \nJoin us online April 22–25\, 2020. There is no cost to attend\, but you must register in advance! \nAt TAGC Online you can join colleagues from the C. elegans\,  Drosophila\, mammalian\, Xenopus\, yeast\, zebrafish\, and population\, evolutionary\, and quantitative genetics (PEQG) research communities—along with other researchers studying humans\, plants\, and agricultural species. In addition to the Community Sessions\, Thematic Sessions bring the communities together around unifying themes. \nOn April 22–25\, both Community and Thematic Sessions will be presented live online. TAGC 2020 Online will also include posters and inspiring Keynote Speakers\, followed by a program of poster discussion sessions and two-hour workshops in the weeks after the main event. TAGC 2020 is organized by dedicated members of the GSA community. We hope you’ll join us for this exciting experiment!
URL:https://scienceinvancouver.com/event/the-allied-genetics-conference-tagc-online-5/
LOCATION:Online
END:VEVENT
END:VCALENDAR